09:22 AM EDT, 07/30/2024 (MT Newswires) -- Arvinas ( ARVN ) reported a Q2 net loss Tuesday of $0.49 per share, narrowing from a loss of $1.25 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.58 per share.

Revenue for the quarter ended June 30 was $76.5 million, up from $54.5 million a year earlier.

Analysts surveyed by Capital IQ expected $70.5 million.

Additionally, the biotechnology company said it has appointed Andrew Saik as its chief financial officer and promoted Angela Cacace to chief scientific officer and Randy Teel to chief business officer.

Price: 28.00, Change: +0.22, Percent Change: +0.79